Global Medical REIT Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2021


		Number of
Date	Description	Units Issued	Vesting Dates

March 2, 2021	Final awards under the 2018 Long-Term Incentive Plan	220	50% on March 2, 2021; and
			50% on March 2, 2022

March 2, 2021	Final awards under the 2020 Annual Incentive Plan	267	50% on March 2, 2021; and
			50% on March 2, 2022

March 2, 2021	Time-based awards under the 2021 Long-Term Incentive Plan	56	100% on March 2, 2024

May 26, 2021	Annual awards to independent directors	25	100% on May 26, 2022

Schedule of time-based vesting LTIP unit activity


Vested units		1,295
Unvested units		912
LTIP Units outstanding as of June 30, 2021		2,207

Schedule of the annual awards and long-term awards

A detail of the Company’s Long-Term Awards under the 2019 and 2020 programs, and the Annual Awards and Long-Term Awards under the 2021 program as of June 30, 2021 is as follows:


2019 Long-Term Awards		82
2020 Long-Term Awards		70
2021 Annual Awards ⁽¹⁾		92
2021 Long-Term Awards ⁽²⁾		76
Total target performance awards as of June 30, 2021		320

(1)	Approved by the Board on March 2, 2021. The number of target LTIP Units was based on the average closing price of the Company’s common stock reported on the New York Stock Exchange (“NYSE”) over the 15 trading days preceding the grant date.

(2)	Approved by the Board on March 2, 2021. The number of target LTIP Units was based on the fair value of the Long-Term Awards as determined by an independent valuation consultant.

Schedule of of the assumptions for the long-term awards using Monte Carlo simulations

Below are details regarding certain of the assumptions for the Long-Term Awards using Monte Carlo simulations:


	2021 Long-Term			2020 Long-Term			2019 Long-Term
	Awards			Awards			Awards

Fair value	$	14.86		$	13.47		$	10.07
Target awards		76			70			82
Volatility		42.37	%		28.75	%		31.7	%
Risk-free rate		0.26	%		0.72	%		2.5	%
Dividend assumption		reinvested			reinvested			reinvested
Expected term in years		3			3			3